98-7893. Agency Information Collection Activities; Submission for OMB Review; Comment Request  

  • [Federal Register Volume 63, Number 58 (Thursday, March 26, 1998)]
    [Notices]
    [Pages 14717-14718]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-7893]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 97N-0489]
    
    
    Agency Information Collection Activities; Submission for OMB 
    Review; Comment Request
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
    proposed collection of information listed below has been submitted to 
    the Office of Management and Budget (OMB) for review and clearance 
    under the Paperwork Reduction Act of 1995 (the PRA).
    
    DATES: Submit written comments on the collection of information by 
    April 26, 1998.
    
    [[Page 14718]]
    
    ADDRESSES: Submit written comments on the collection of information to 
    the Office of Information and Regulatory Affairs, OMB, New Executive 
    Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: 
    Desk Officer for FDA.
    
    FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
    
    SUPPLEMENTARY INFORMATION: In compliance with section 3507 of the PRA 
    (44 U.S.C. 3507), FDA has submitted the following proposed collections 
    of information to OMB for review and clearance.
    
    Petition For Administrative Reconsideration of Action--21 CFR 
    10.33--(OMB Control Number 0910-0192--Reinstatement)
    
        Section 10.33 (21 CFR 10.33), issued under section 701(a) of the 
    Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 371(a)), sets 
    forth the format and procedures by which an interested person may 
    petition the Commissioner of Food and Drugs (the Commissioner) for 
    reconsideration of an agency's action. A petition for reconsideration 
    must contain a full statement in a well-organized format of the factual 
    and legal grounds upon which the petition relies. The grounds must 
    demonstrate that relevant information and views contained in the 
    administrative record were not previously or not adequately considered 
    by the Commissioner. Each petition must be submitted no later than 30 
    days after the decision involved. The Commissioner may, for good cause, 
    permit a petition to be filed after 30 days. An interested person who 
    wishes to rely on information or views not included in the 
    administrative record shall submit them with a new petition to modify 
    the decision. FDA uses the information provided to determine whether to 
    grant the petition for reconsideration. Respondents to this collection 
    of information are individuals of households, State or local 
    governments, not-for-profit institutions, and businesses or other for-
    profit institutions.
        FDA estimates the burden of this collection of information as 
    follows:
    
                                      Table  1.--Estimated Annual Reporting Burden1                                 
    ----------------------------------------------------------------------------------------------------------------
                                                          Annual                                                    
             21 CFR Section               No. of       Frequency per   Total Annual      Hours per      Total Hours 
                                        Respondents      Response        Responses       Response                   
    ----------------------------------------------------------------------------------------------------------------
    10.33(b)                                7               1               7              10              70       
    ----------------------------------------------------------------------------------------------------------------
    \1\ There are no capital costs or operating and maintenance costs associated with this collection of            
      information.                                                                                                  
    
        Due to a typographical error, the total burden hours were reported 
    as 700 in FDA's December 16, 1997 (62 FR 65812), notice providing 60 
    days for public comment on this collection of information. The total 
    has been corrected to 70. The burden estimate for this collection of 
    information is based on agency records and experience over the past 3 
    years. Agency personnel handling the petitions for administrative 
    reconsideration of an action estimate approximately seven requests 
    being received by the agency annually, each requiring an average of 10 
    hours preparation time.
    
        Dated: March 18, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-7893 Filed 3-25-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
03/26/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-7893
Dates:
Submit written comments on the collection of information by April 26, 1998.
Pages:
14717-14718 (2 pages)
Docket Numbers:
Docket No. 97N-0489
PDF File:
98-7893.pdf